Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes

Lymphokine and Cytokine Research

Volumn 10, Issue 1-2, 1991, Pages 7-13

  Taupin, V ^a   Herbelin, A ^a   Descamps Latscha, B ^a   Zavala, F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4' CHLORODIAZEPAM; BENZODIAZEPINE DERIVATIVE; BETA CARBOLINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; OCTADECANEUROPEPTIDE; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTI-ANXIETY AGENTS, BENZODIAZEPINE; BENZODIAZEPINONES; BIOLOGICAL ASSAY; DIAZEPAM BINDING INHIBITOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MONOCYTES; NEUROPEPTIDES; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR;

EID: 0025910167     PISSN: 02776766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)